Low-code pipeline canvas
Drag, drop, and lock vision workflows — ingestion, de-identification, normalization, inference, and structured reporting — without writing code.
LOTUS CHAIN Hub partners with entrepreneurs building in healthcare, AI, and research-heavy markets. We bring product strategy, technical execution, and commercialization support under one roof — with DiagFlow, our active low-code platform for governed medical vision AI, at the center.
Active platform
Assemble, run, and audit multimodal diagnostic pipelines — low-code, browser-first, human-in-the-loop.
Explore DiagFlow
The active platform
DiagFlow is the base product of BLUE LOTUS / Lotuschain.org, engineered by VisionLAB. It turns model availability into clinical workflow reality — a low-code canvas where clinicians orchestrate multimodal pipelines that run locally via WebGPU/WASM, are governed by immutable audit graphs, and are validated by mandatory human review.
Drag, drop, and lock vision workflows — ingestion, de-identification, normalization, inference, and structured reporting — without writing code.
WebGPU/WASM executes models on the clinician's own hardware: ~90%+ cloud compute cost reduction and privacy by design.
No output crosses into a report without explicit clinician review, override, and an append-only audit trail.
Medical creators publish and monetize immutable workflow templates under a 90% creator / 10% platform revenue split.
De-identification gates, model cards, validation packages, and fail-closed egress — built for HIPAA and beyond.
A beachhead in academic imaging labs scaling to departmental teams, enterprise VPCs, and DICOMweb/FHIR connectivity.
Current focus areas
We prioritize applied AI opportunities where domain depth, clinical trust, and workflow integration matter.

A cross-border healthcare initiative designed to reduce friction between patients and specialist surgical services in the Middle East.
How we help
Our model is built for technically ambitious founders who need execution support, sharper positioning, and trust-building from day one.
Pressure-test the opportunity with market framing, user research, and realistic product assumptions.
Move from concept to MVP with support across AI systems, product architecture, and delivery planning.
Shape solutions around evidence, healthcare workflows, and domain-specific credibility requirements.
Tap into a growing network of founders, operators, researchers, partners, and strategic backers.
Portfolio direction
Three initiatives define our current direction: the active DiagFlow platform, Lotus Health diagnostics, and Oxin Surgery's cross-border care coordination.

The low-code, browser-first platform for governed multimodal diagnostic pipelines — from ingestion and de-identification to local inference and human-reviewed reporting.

Diagnostic support workflows combining imaging analysis, medical reasoning, and structured insight generation for breast cancer workflows.

Cross-border care coordination designed to improve access to specialist surgical procedures and patient support.
Journey
A concise view of how the studio sharpened its direction from broad experimentation to focused healthcare and AI execution.
Founder intake
Share the problem, the current stage, and where you need help. We are especially interested in healthcare AI, research-heavy software, and defensible technical products.